Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases

Journal: Science Advances

Published: 2020-02-01

DOI: 10.1126/sciadv.aav7504

Affiliations: 11

Authors: 19

Go to article
Institutions Share
Department of Chemistry, GSU, United States of America (USA) 0.29
The Winship Cancer Institute of Emory University, United States of America (USA) 0.16
Emory Eye Center, Emory University, United States of America (USA) 0.11
Emory Yerkes National Primate Research Center, United States of America (USA) 0.11
Inlighta Biosciences LLC, United States of America (USA) 0.05
Bio-imaging Research Center (BIRC), UGA, United States of America (USA) 0.05
Department of Biology, GSU, United States of America (USA) 0.05
Department of Mathematics and Statistics, GSU, United States of America (USA) 0.05
Hamilton Eye Institute (HEI), UTHSC, United States of America (USA) 0.05
Department of Radiology, Augusta University, United States of America (USA) 0.05
Center for Diagnostics and Therapeutics (CDT), GSU, United States of America (USA) 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER